{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:48:13Z","timestamp":1794084493794,"version":"4.8.0"},"reference-count":54,"publisher":"IOP Publishing","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/iop-standard\/v1"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/iopscience.iop.org\/info\/page\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/questions\/alternative-author-rights-policies\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publishingsupport.iopscience.iop.org\/questions\/alternative-author-rights-policies\/"}],"funder":[{"name":"the National Key Research and Development Program of China","award":["No.2023YFC2412300"],"award-info":[{"award-number":["No.2023YFC2412300"]}]},{"name":"Shenzhen Science and Technology Project","award":["JCYJ20220818103207016"],"award-info":[{"award-number":["JCYJ20220818103207016"]}]},{"name":"the Natural Science Foundation of Guangdong Province","award":["2022A1515010024"],"award-info":[{"award-number":["2022A1515010024"]}]}],"content-domain":{"domain":["iopscience.iop.org"],"crossmark-restriction":false},"short-container-title":["Biofabrication"],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The fibrotic stroma drives tumor progression and impairs therapy, but existing models fail to capture its dual barrier and signaling roles, limiting mechanistic understanding and therapeutic development. To address this, we established a patient-derived fibrotic tumor model that recapitulates key pathophysiological features: extracellular matrix remodeling, substantial tissue stiffening (12-fold increase), and pro-malignant transcriptomic reprogramming. This model demonstrated microenvironment-mediated chemoresistance, increasing the area under the dose\u2010response curve by 1.3-fold and suppressing oxaliplatin-induced apoptosis. Although stiffening delayed drug penetration, barrier disruption did not restore sensitivity. Instead, stiffness inactivated the Hippo pathway, activating YAP as the key chemoprotection driver. YAP inhibition restored drug sensitivity without altering stiffness, revealing a targetable biochemical mechanism independent of the physical barrier. Using this insight, we designed a sequential regimen in which nintedanib preconditioning precedes chemotherapy, achieving near-complete tumor eradication (&lt;5% tumor viability). This work provides a physiological model of stromal biology and a mechanism-guided strategy to overcome microenvironment-mediated chemoresistance.<\/jats:p>","DOI":"10.1088\/1758-5090\/ae6f84","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T22:56:33Z","timestamp":1779144993000},"page":"035001","update-policy":"https:\/\/doi.org\/10.1088\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting the YAP-mediated stromal signaling unlocks chemoresistance in a human organoid fibrosis model"],"prefix":"10.1088","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4080-6467","authenticated-orcid":true,"given":"Duoer","family":"Xiong","sequence":"first","affiliation":[{"name":"Shenzhen Campus of Sun Yat-Sen University"},{"name":"Sun Yat-Sen University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8114-3827","authenticated-orcid":true,"given":"Qihang","family":"Zheng","sequence":"additional","affiliation":[{"name":"Shenzhen Campus of Sun Yat-Sen University"},{"name":"Sun Yat-Sen University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[{"name":"The Seventh Affiliated Hospital of Sun Yat-Sen University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"Li","sequence":"additional","affiliation":[{"name":"Shenzhen Campus of Sun Yat-Sen University"},{"name":"Sun Yat-Sen University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Chen","sequence":"additional","affiliation":[{"name":"Shenzhen Campus of Sun Yat-Sen University"},{"name":"Sun Yat-Sen University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhua","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Seventh Affiliated Hospital of Sun Yat-Sen University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6035-0131","authenticated-orcid":true,"given":"Jie","family":"Liu","sequence":"additional","affiliation":[{"name":"Shenzhen Campus of Sun Yat-Sen University"},{"name":"Sun Yat-Sen University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"266","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"bfae6f84bib1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41568-025-00798-8","type":"journal-article","article-title":"The fibroinflammatory response in cancer","volume":"25","author":"XIAO","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"bfae6f84bib2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41392-024-01872-7","type":"journal-article","article-title":"Engineered extracellular vesicles for targeted reprogramming of cancer-associated fibroblasts to potentiate therapy of pancreatic cancer","volume":"9","author":"ZHOU","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"bfae6f84bib3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-022-01569-x","type":"journal-article","article-title":"Targeting TGF-\u0392 signal transduction for fibrosis and cancer therapy","volume":"21","author":"PENG","year":"2022","journal-title":"Mol. Cancer"},{"key":"bfae6f84bib4","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303230","type":"journal-article","article-title":"Cancer-associated fibroblast-induced remodeling of tumor microenvironment in recurrent bladder cancer","volume":"10","author":"Liang","year":"2023","journal-title":"Adv. Sci."},{"key":"bfae6f84bib5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123725","type":"journal-article","article-title":"Engineered bacterial outer membrane vesicles enhanced tumor immunotherapy through remodeling tumor stroma and targeted delivery of cd73 sirna","volume":"327","author":"CHENG","year":"2025","journal-title":"Biomaterials"},{"key":"bfae6f84bib6","doi-asserted-by":"publisher","first-page":"7248","DOI":"10.1016\/j.cell.2024.09.032","type":"journal-article","article-title":"IRE1a silences DSRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer","volume":"187","author":"XU","year":"2024","journal-title":"Cell"},{"key":"bfae6f84bib7","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1158\/2159-8290.CD-23-1445","type":"journal-article","article-title":"Single-cell chromatin accessibility analysis reveals the epigenetic basis and signature transcription factors for the molecular subtypes of colorectal cancers","volume":"14","author":"LIU","year":"2024","journal-title":"Cancer Discov."},{"key":"bfae6f84bib8","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101576","type":"journal-article","article-title":"Alarmin S100a8 imparts chemoresistance of esophageal cancer by reprogramming cancer-associated fibroblasts","volume":"5","author":"Chen","year":"2024","journal-title":"Cell Rep. Med."},{"key":"bfae6f84bib9","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70415","type":"journal-article","article-title":"Integrative single-cell transcriptomic analysis deciphers heterogeneous characteristics of gastrointestinal tract cancer","volume":"15","author":"Sun","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"bfae6f84bib10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.ccell.2023.12.002","type":"journal-article","article-title":"EGFR-activated myofibroblasts promote metastasis of pancreatic cancer","volume":"42","author":"Mucciolo","year":"2024","journal-title":"Cancer Cell"},{"key":"bfae6f84bib11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13045-024-01643-5","type":"journal-article","article-title":"myCAF-derived exosomal PWAR6 accelerates CRC liver metastasis via altering glutamine availability and NK cell function in the tumor microenvironment","volume":"17","author":"Fang","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"bfae6f84bib12","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.ccell.2023.03.001","type":"journal-article","article-title":"Epithelial cells activate fibroblasts to promote esophageal cancer development","volume":"41","author":"Chen","year":"2023","journal-title":"Cancer Cell"},{"key":"bfae6f84bib13","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.1038\/s41467-020-19920-5","type":"journal-article","article-title":"TGF\u03b2-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts","volume":"11","author":"Grauel","year":"2020","journal-title":"Nat. Commun."},{"key":"bfae6f84bib14","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1158\/2159-8290.CD-22-1467","type":"journal-article","article-title":"Oncogenic KRAS drives lipofibrogenesis to promote angiogenesis and colon cancer progression","volume":"13","author":"Hsu","year":"2023","journal-title":"Cancer Discov."},{"key":"bfae6f84bib15","doi-asserted-by":"publisher","first-page":"eadj5705","DOI":"10.1126\/scitranslmed.adj5705","type":"journal-article","article-title":"Tspan8(+) myofibroblastic cancer-associated fibroblasts promote chemoresistance in patients with breast cancer","volume":"16","author":"Fan","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"bfae6f84bib16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.actbio.2020.12.037","type":"journal-article","article-title":"Hydrogel-based colorectal cancer organoid co-culture models","volume":"132","author":"Luo","year":"2021","journal-title":"Acta Biomater."},{"key":"bfae6f84bib17","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202404642","type":"journal-article","article-title":"Bioprinted fibroblast mediated heterogeneous tumor microenvironment for studying tumor-stroma interaction and drug screening","volume":"14","author":"Chen","year":"2025","journal-title":"Adv. Healthcare Mater."},{"key":"bfae6f84bib18","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s13046-022-02519-7","type":"journal-article","article-title":"Patient-specific modeling of stroma-mediated chemoresistance of pancreatic cancer using a three-dimensional organoid-fibroblast co-culture system","volume":"41","author":"Schuth","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"bfae6f84bib19","doi-asserted-by":"publisher","first-page":"5606","DOI":"10.1016\/j.cell.2023.11.005","type":"journal-article","article-title":"Trellis tree-based analysis reveals stromal regulation of patient-derived organoid drug responses","volume":"186","author":"Ramos Zapatero","year":"2023","journal-title":"Cell"},{"key":"bfae6f84bib20","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1158\/2159-8290.CD-23-0050","type":"journal-article","article-title":"Colorectal cancer organoid-stroma biobank allows subtype-specific assessment of individualized therapy responses","volume":"13","author":"Farin","year":"2023","journal-title":"Cancer Discov."},{"key":"bfae6f84bib21","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1038\/s41467-024-47737-z","type":"journal-article","article-title":"A patient-specific lung cancer assembloid model with heterogeneous tumor microenvironments","volume":"15","author":"ZHANG","year":"2024","journal-title":"Nat. Commun."},{"key":"bfae6f84bib22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bioactmat.2025.05.025","type":"journal-article","article-title":"A dual-targeting strategy to inhibit colorectal cancer liver metastasis via tumor cell ferroptosis and cancer-associated fibroblast reprogramming","volume":"52","author":"Wu","year":"2025","journal-title":"Bioact. Mater."},{"key":"bfae6f84bib23","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","type":"journal-article","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"key":"bfae6f84bib24","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41392-022-01070-3","type":"journal-article","article-title":"Targeting fibrosis, mechanisms and clinical trials","volume":"7","author":"ZHAO","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"bfae6f84bib25","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202410416","type":"journal-article","article-title":"Targeting fibrosis: from molecular mechanisms to advanced therapies","volume":"12","author":"Di","year":"2025","journal-title":"Adv. Sci."},{"key":"bfae6f84bib26","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101627","type":"journal-article","article-title":"Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer","volume":"5","author":"ZHAO","year":"2024","journal-title":"Cell Rep. Med."},{"key":"bfae6f84bib27","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.ccell.2025.03.004","type":"journal-article","article-title":"Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics","volume":"43","author":"LIU","year":"2025","journal-title":"Cancer Cell"},{"key":"bfae6f84bib28","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12226","type":"journal-article","article-title":"Epithelial to mesenchymal transition influences fibroblast phenotype in colorectal cancer by altering MIR-200 levels in extracellular vesicles","volume":"11","author":"Bhome","year":"2022","journal-title":"J. Extracell. Vesicles"},{"key":"bfae6f84bib29","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102296","type":"journal-article","article-title":"Toripalimab, bevacizumab, and irinotecan in DMMR\/MSI locally advanced colorectal cancer: first-stage results from a phase 1b\/2 trial","volume":"6","author":"Wang","year":"2025","journal-title":"Cell Rep. Med."},{"key":"bfae6f84bib30","doi-asserted-by":"publisher","DOI":"10.1177\/17588359241303302","type":"journal-article","article-title":"Enhancing efficacy of the MEK inhibitor trametinib with paclitaxel in KRAS-mutated colorectal cancer","volume":"16","author":"Ghosh","year":"2024","journal-title":"Ther. Adv. Med. Oncol."},{"key":"bfae6f84bib31","doi-asserted-by":"publisher","first-page":"9501","DOI":"10.2147\/DDDT.S556619","type":"journal-article","article-title":"Chronic inflammatory comprehensive signature predicts oxaliplatin and 5-Fluorouracil benefit in early colorectal cancer","volume":"19","author":"PENG","year":"2025","journal-title":"Drug Des. Dev. Ther."},{"key":"bfae6f84bib32","doi-asserted-by":"publisher","first-page":"5559","DOI":"10.1038\/s41467-025-60119-3","type":"journal-article","article-title":"Sintilimab and anlotinib with gemcitabine plus cisplatin in advanced biliary tract cancer: SAGC a randomized phase 2 trial","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"key":"bfae6f84bib33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4196\/kjpp.24.274","type":"journal-article","article-title":"Enhancing doxorubicin\u2019s anticancer impact in colorectal cancer by targeting the Akt\/Gsk3\u03b2\/Mtor-Srebp1 signaling axis with an HDAC inhibitor","volume":"29","author":"ZHAO","year":"2025","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"bfae6f84bib34","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202402795","type":"journal-article","article-title":"MAPK signaling-mediated RFNG phosphorylation and nuclear translocation restrain oxaliplatin-induced apoptosis and ferroptosis","volume":"11","author":"Di","year":"2024","journal-title":"Adv. Sci."},{"key":"bfae6f84bib35","doi-asserted-by":"publisher","first-page":"23740","DOI":"10.1021\/acsami.5c03195","type":"journal-article","article-title":"Engineered NK exosomes captured antigens in situ for enhanced tumor immunotherapy","volume":"17","author":"PENG","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"bfae6f84bib36","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41467-023-36334-1","type":"journal-article","article-title":"Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy","volume":"14","author":"Linares","year":"2023","journal-title":"Nat. Commun."},{"key":"bfae6f84bib37","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.1582-4934.2010.01236.x","type":"journal-article","article-title":"Proteoglycans in cancer biology, tumour microenvironment and angiogenesis","volume":"15","author":"Iozzo","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"bfae6f84bib38","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201906745","type":"journal-article","article-title":"A size-changeable collagenase-modified nanoscavenger for increasing penetration and retention of nanomedicine in deep tumor tissue","volume":"32","author":"XU","year":"2020","journal-title":"Adv. Mater."},{"key":"bfae6f84bib39","doi-asserted-by":"publisher","first-page":"eadr8001","DOI":"10.1126\/sciadv.adr8001","type":"journal-article","article-title":"Pulsatile sequential drug release system for cascade tumor deep penetration and differentiation therapy to enhance chemoimmunotherapy","volume":"11","author":"LIU","year":"2025","journal-title":"Sci. Adv."},{"key":"bfae6f84bib40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","type":"journal-article","article-title":"Role of YAP\/TAZ in mechanotransduction","volume":"474","author":"Dupont","year":"2011","journal-title":"Nature"},{"key":"bfae6f84bib41","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","type":"journal-article","article-title":"Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling","volume":"572","author":"Wu","year":"2019","journal-title":"Nature"},{"key":"bfae6f84bib42","doi-asserted-by":"publisher","DOI":"10.1088\/1758-5090\/adf099","type":"journal-article","article-title":"Engineered tumor microspheres via microfluidics and decellularized extracellular matrix for high-throughput organoid-based drug screening","volume":"17","author":"JIN","year":"2025","journal-title":"Biofabrication"},{"key":"bfae6f84bib43","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.hbpd.2022.06.004","type":"journal-article","article-title":"Yap activates pancreatic stellate cells and enhances pancreatic fibrosis","volume":"21","author":"Spanehl","year":"2022","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"bfae6f84bib44","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.1158\/1078-0432.CCR-24-1518","type":"journal-article","article-title":"High mechanical conditioning by tumor extracellular matrix stiffness is a predictive biomarker for antifibrotic therapy in HER2-negative breast cancer","volume":"30","author":"Quintela-fandino","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"bfae6f84bib45","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41698-025-00926-5","type":"journal-article","article-title":"SHMT inhibitor synergizes with 5-Fu to suppress gastric cancer via cell cycle arrest and chemoresistance alleviation","volume":"9","author":"Deng","year":"2025","journal-title":"NPJ Precis. Oncol."},{"key":"bfae6f84bib46","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40164-025-00647-2","type":"journal-article","article-title":"Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer","volume":"14","author":"Zhang","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"bfae6f84bib47","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202307206","type":"journal-article","article-title":"mTORC1 mediates biphasic mechano-response to orchestrate adhesion-dependent cell growth and anoikis resistance","volume":"11","author":"Zhang","year":"2024","journal-title":"Adv. Sci."},{"key":"bfae6f84bib48","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/s43018-024-00758-5","type":"journal-article","article-title":"Fibrotic tumors tune metabolism for immune evasion","volume":"5","author":"Perricone","year":"2024","journal-title":"Nat. Cancer."},{"key":"bfae6f84bib49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI180802","type":"journal-article","article-title":"Metastatic tumor growth in steatotic liver is promoted by HAS2-mediated fibrotic tumor microenvironment","volume":"135","author":"Yang","year":"2025","journal-title":"J. Clin. Invest."},{"key":"bfae6f84bib50","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jcmgh.2020.09.003","type":"journal-article","article-title":"Cancer-associated fibroblasts provide a stromal niche for liver cancer organoids that confers trophic effects and therapy resistance","volume":"11","author":"Liu","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"bfae6f84bib51","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.ijrobp.2022.12.029","type":"journal-article","article-title":"Cancer-associated fibroblasts promote radioresistance of breast cancer cells via the HGF\/c-met signaling pathway","volume":"116","author":"Wang","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"bfae6f84bib52","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12967-025-06236-5","type":"journal-article","article-title":"Single-cell and spatial transcriptome profiling reveal CTHRC1+fibroblasts promote EMT through WNT5a signaling in colorectal cancer","volume":"23","author":"Lu","year":"2025","journal-title":"J. Transl. Med."},{"key":"bfae6f84bib53","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2421061122","type":"journal-article","article-title":"Sequential drug release system: targeting the tumor ECM for enhanced chemotherapy efficacy","volume":"122","author":"Cao","year":"2025","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"bfae6f84bib54","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41392-025-02217-8","type":"journal-article","article-title":"Bio-barrier-adaptable biomimetic nanomedicines combined with ultrasound for enhanced cancer therapy","volume":"10","author":"Guo","year":"2025","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Biofabrication"],"original-title":[],"link":[{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1758-5090\/ae6f84","content-type":"text\/html","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1758-5090\/ae6f84\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1758-5090\/ae6f84","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1758-5090\/ae6f84\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1758-5090\/ae6f84\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1758-5090\/ae6f84\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1758-5090\/ae6f84\/pdf","content-type":"application\/pdf","content-version":"am","intended-application":"similarity-checking"},{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1758-5090\/ae6f84\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T11:09:22Z","timestamp":1780312162000},"score":1,"resource":{"primary":{"URL":"https:\/\/iopscience.iop.org\/article\/10.1088\/1758-5090\/ae6f84"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6,1]]},"published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1088\/1758-5090\/ae6f84","relation":{},"ISSN":["1758-5082","1758-5090"],"issn-type":[{"value":"1758-5082","type":"print"},{"value":"1758-5090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"Targeting the YAP-mediated stromal signaling unlocks chemoresistance in a human organoid fibrosis model","name":"article_title","label":"Article Title"},{"value":"Biofabrication","name":"journal_title","label":"Journal Title"},{"value":"paper","name":"article_type","label":"Article Type"},{"value":"\u00a9 2026 IOP Publishing Ltd. All rights, including for text and data mining, AI training, and similar technologies, are reserved.","name":"copyright_information","label":"Copyright Information"},{"value":"2026-02-19","name":"date_received","label":"Date Received","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2026-05-18","name":"date_accepted","label":"Date Accepted","group":{"name":"publication_dates","label":"Publication dates"}},{"value":"2026-06-01","name":"date_epub","label":"Online publication date","group":{"name":"publication_dates","label":"Publication dates"}}]}}